1CIBIS=Ⅱ investigator and Committees. The Cardiac Insufficiency Bisoprolol Study Ⅱ: (CIBIS=Ⅱ) a randomized trial. Lancet,1999, 353:9-13.
2The metoprolol in Dilated Cardiomyopathy (MDC) . trial Study Group. 3-year follow-up of a patients randomized in the metoprolol in Dilated Cardlomyopathy trial. Lancet, 1998, 349:376-380.
1The Cardiac Insufficiency Bisoprolol Study Ⅱ (CIBIS Ⅱ ): a randomised trial. Lancet, 1999, 353: 9-13.
2Doughty RN, Rodgers A, Sharpe N, et al. Effects of beta-blocker therapy on mortality in patients with heart failure: a systematic overview of randomized controlled trials. Eur Heart J, 1997, 8: 560-565.
3Heidentich PA, Lee TT, Massie BM. Effects of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol, 1997, 30: 27-34.
4Lechat P, Packer M, Chalon S, et al. Beta-blockers in heart failure:meta-analysis of randomized trial. Circulation, 1998, 98: 1184-1191.
5O′Leary CJ;Jones PW.The left ventricular dysfunction questionnaire (LVD-36):reliability,validity,and responsiveness[J],2000(83).
6Saif S;Yongfei W;Harlan M.Sex-based differences in the effect of digoxin for the treatment of heart failure[J],2002(18).
7MERIT-HF Study Group.查看详情,1999.
8CIBIS-II Investigator;Committees.The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial,1999.
9Packer M;Bristow MR;Cohn JN.The effect of Carvedilol on mortality in patients with chronic heart failure[J],1996.
10Packer M;Coats AJ;Fowler MB.Effect of carvedilol on survival in severe chronic heart failure[J],2001.
4[5]Report of the American Collgeg of Cardiology/American Heart Association Task Force on Practice Guidelines(Committee on Evaluation and Management of Heart Failure).Guiddunes for the evaluation and management of heart failure[J].J Am Coil Cardioe,20055,13:1076-1078.
